SAA1 and Insulin resistance: Consistent with this finding, AT-specific human SAA1(+/-) transgenic mice also showed no differences in HFD-induced obesity, insulin resistance, and obesity-related inflammation (172), ruling out the possible role of SAA1 in human obesity and associated inflammation.